CN110297056A - A kind of preparation and application of isobar tagging reagents - Google Patents
A kind of preparation and application of isobar tagging reagents Download PDFInfo
- Publication number
- CN110297056A CN110297056A CN201910582411.9A CN201910582411A CN110297056A CN 110297056 A CN110297056 A CN 110297056A CN 201910582411 A CN201910582411 A CN 201910582411A CN 110297056 A CN110297056 A CN 110297056A
- Authority
- CN
- China
- Prior art keywords
- compound
- isobar
- group
- tagging reagents
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
The invention discloses a kind of isobar tagging reagents, the structure feature of isobar tagging reagents includes following formula: reporter group-balance group-activated group, isobar tagging reagents include 10 identical tagging reagents of chemical structure, different location in each tagging reagents contains 13C or 15N isotope, and isobar tagging reagents include: T-114, T-115N, T-115C, T-116N, T-116C, T-117N, T-118N, T-117C, T-118C, T-119;The method for preparing the isobar tagging reagents is also disclosed simultaneously, is also disclosed using the isobar tagging reagents to polypeptide quantitative analysis method.IBT-10PLEX in the present invention uses novel chemical structure, reduces the difficulty of preparation, improves yield, so as to reduce the cost of product, expands the use scope of isobar labelling method.
Description
Technical field
The present invention relates to biomolecule analysis reagent fields, are especially used for biomolecule quantitative analysis, particularly for
A kind of preparation of quantitative isobar tagging reagents of the isobar (isobaric) containing 10 labels of proteomics and
Using.
Background technique
It mainly include unmarked analytic approach and label currently based on the quantitative approach of the proteomics of mass-spectrometric technique detection
Method, and labelling method is divided into based on the method that first mass spectrometric (MS1) is quantitative and second order ms (MS2) are quantitative, wherein isobar
Isotope labelling belongs to the analysis method based on MS2.
Compared with unmarked analytic approach and MS1 labelling method, MS2 labelling method advantage is:
1) analysis time of Bulk Samples can be substantially reduced.
2) it is mixed in advance before liquid phase series connection (LC-MS/MS) mass spectral analysis due to the different samples of isobar label
It closes, so that whole samples are completed in a LC-MS/MS analysis, effectively reduces different samples in different LC-MS/MS
Systematic error.Isobar labeling method can reduce what different samples generated in not herewith measurement to the maximum extent
Difference solves the problems, such as the unavoidable repeatability in the analysis method that no label marks.
3) multiple samples mix after isobar reagent label, same polypeptide contained in different samples point
Son is merged together, and is equivalent to and is enhanced sample concentration, and corresponding MS/MS fragment signal becomes stronger, makes the sensitive of detection
Degree greatly improves.
4) based on the labeling method of MS1, the amino acid containing stable isotope labeling is generally added in cell culture medium
(SILAC labelling method).In contrast, isobar MS2 labeling method is eased, reduce the former answering in chromatographic isolation
Polygamy is more applicable for the comparative analysis of multiple samples.
5) arginine or bad ammonia element of the quantitative approach dependent on cellular uptake containing stable isotope based on SILAC label close
At albumen, and then contain the protein of labeled amino acid containing these again.This method only may be implemented in the cell of culture,
But in bacterium, animal tissue is difficult to apply in the analysis of human sample and realize.In contrast, isobar isotope MS2 is marked
Note will not then be limited by samples sources.
Obviously, isobar labelling method is one of most popular method during proteomics is quantitative.However, existing on the market
Commercialized isobar labelled reagent valuable product become many especially for the sample for largely needing to mark
The financial burden in laboratory and it is maximum apply obstacle.
Summary of the invention
To solve the above problems, the invention discloses a kind of isobars for MS2 fragment label to contain 10 labels
The preparation and application of reagent (IBT-10PLEX).Reagent contain 10 kinds of label labels can different samples of 10 kinds of label simultaneously, it is complete
The full polypeptide quantitative analysis for being suitable for multiple proteins group.
In order to reach the goals above, the invention provides the following technical scheme:
Isobar tagging reagents (IBT-10PLEX reagent): shear key and isotopic tag can be contained comprising MS/MS
Polypeptide can be marked and quantified with the group of polypeptides reactive.Its structure includes following formula: reporter group-balance group-work
Change group, wherein reporter group and balance group, which pass through MS/MS, can shear key connection.IBT-10PLEX reagent labeling polypeptide it is anti-
Polypeptide after answering and marking cracks the structure such as following figure of the reporter group of formation in tandem mass spectrum.
A whole set of reagent includes 10 identical tagging reagents of chemical structure, the different location in each tagging reagents
Contain 13C or 15N isotope.Therefore the quality of reporter group is different, but the different quality of reporter group is balanced base
Group is compensated.Reporter group+balance group quality in each reagent is identical.Reporter group and balance group pass through can
Shearing key connection, shear key are preferentially broken in MS/MS, generate a series of reporter group ions, be respectively provided with different molecules
Formula and quality, the specific molecular formula and accurate mass of reporter group ion are as follows:
Its corresponding chemical structure is as follows, and wherein asterisk label represents the position of isotope 15N and 13C.
Wherein in the range of 114 to 119Da, the reagent contains independently selected from 13C the quality of the reporter group
And/or the isotope atom combination of the different number and location of 15N, and identification and analysis is carried out by mass spectrum;Identification and analysis step
It is as follows:
1) liquid chromatogram separation is carried out using nanometer reverse-phase chromatographic column;
2) it is analyzed using peptide identification of the Orbitrap Q Exactive high-resolution mass spectrometer to label;
3) it is at least the 5% of peak-peak using the signal strength of the signal reports group ion of quantitative analysis.
IBT-10PLEX reagent can directly be marked 10 kinds of polypeptide samples.It is mixed for LC-MS/ after the completion of label
MS analysis.Since reporter group and balance group can shear key connection by mass spectrum MS/MS, it is cut off in Tandem Mass Spectrometry Analysis
Be formed by report ion difference in quality can be analyzed with high resolution mass spectrum after for quantitative.Further, since IBT-
10PLEX contains only 13C and 15N isotope, and without containing another common isotope deuterium, avoid relevant color caused by deuterium
Spectral displacement, it is ensured that dosing accuracy.
The invention also discloses a kind of methods for synthesizing 7 kinds of isotopic tags, using the raw material β-for containing different isotopes
Ala-OBzl, Boc-Gly-OH, propionic aldehyde synthesize 7 kinds of isotopic tags T-114, T-115N, T-115C, T- according to following methods
116N,T-116C,T-117N,T-118N;
Specific step is as follows:
1) 1 β-Ala-OBzl.HCl of compound and compound 2Boc-Gly-OH are coupled to compound 3;
2) compound 3 sloughs Boc group in acid condition, forms compound 4;
3) compound 4 and propionic aldehyde form compound 5 under reducing agent NaCNBH3 effect;
4) compound 5 and hydrogen slough Bzl blocking group under the catalytic action of palladium carbon and form compound 6;
5) compound 6 forms the IBT reagent compound 7 of activation with NHS under the action of dehydrating agent EDC;
Process route is as follows:
The invention also discloses the methods of 3 kinds of isotopic tags of synthesis, using the raw material β-Ala- for containing different isotopes
Obzl, Boc-Gly-OH, propionic aldehyde synthesize 3 kinds of isobar tagging reagents, including T-117C, T-118C, T- according to following methods
119;Specific step is as follows:
1) 2-Nosyl-Gly-OH (compound 8) reacts to form compound 9 with iodopropane;
2) compound 9 is deprotected under the conditions of 2 mercapto ethanol and potassium hydroxide and forms compound 10;
3) compound 11 is formed plus Boc blocking group on the second level amino of compound 10;
4) β-Ala-OBzl.HCl (compound 1) and compound 11 are coupled to compound 12;
5) compound 12 sloughs Boc group in acid condition, forms compound 13;
6) compound 13 and propionic aldehyde form compound 5 under reducing agent (NaCNBH3) effect;
7) compound 5 and hydrogen slough Bzl blocking group under the catalytic action of palladium carbon and form compound 6;
8) compound 6 forms the IBT reagent compound 7 of activation with NHS under the action of dehydrating agent EDC;
The application of IBT-10PLEX reagent: IBT-10PLEX reagent is used for polypeptide quantitative analysis, and key step includes label,
Molecular fragment, quantitative three steps.After most 10 polypeptide samples can be marked respectively by IBT-10PLEX reagent, it is blended in one
It rises, is then separated on liquid chromatogram LC, and then generate fragments characteristic peak and reagent reporter group in MS/MS, according to spy
The intensity for levying peak and reporter group carries out qualitative, quantitative analysis to polypeptide.
Wherein, polypeptide is prepared by the following:
(1) from the albumen of cell extraction
(2) pass through trypsin digestion
(3) desalination obtains mixtures of polypeptides
Wherein polypeptide is obtained from cell culture or other samples.
The preparation of sample may come from the protein ingredient extracted in the cell or other biological sample of culture.
The invention also discloses a kind of isobar tagging reagents, wherein isobar tagging reagents equally contain 13C and
The equivalent dystopy isotopic tag of 15N, the isobar tagging reagents include following structure A, structure B, structure C, structure D or
The one or more of them of person's structure E:
The invention has the following beneficial effects:
IBT-10PLEX in the present invention uses novel chemical structure, reduces the difficulty of preparation, improves yield,
So as to reduce the cost of product, expand the use scope of isobar labelling method.
The present invention has intrinsic efficient, high-throughput, the highly sensitive feature of all isobar reagents, while improving it
The defect of his similar reagent has low cost.
Reagent of the invention contain 10 kinds of label labels can different samples of 10 kinds of label simultaneously, be completely suitable for a variety of eggs
The polypeptide quantitative analysis of white matter group.
Detailed description of the invention
Influence datagram of the ratio of Fig. 1 (A) IBT-10PLEX reagent and peptide to labeling effciency;
Fig. 1 (B) IBT-10PLEX reagent marks influence datagram of the reaction time to labeling effciency;
Optimal LC-MS/MS mass spectral analysis condition-point needed for Fig. 2 (A): IBT-10PLEX labelled protein quantitative analysis
The influence datagram that resolution distinguishes reporter group ion;
Optimal LC-MS/MS mass spectral analysis condition-NCE needed for Fig. 2 (B): IBT-10PLEX labelled protein quantitative analysis
(orthogonal collision energy) is identified IBT labeling polypeptide and the influence datagram of IBT report ionic strength;
Fig. 3 (A): the datagram of the accuracy-IBT-10PLEX labeling effciency of IBT-10PLEX reagent quantitative;
Fig. 3 (B): the data of the quantitative linearity scope of the accuracy-IBT-10PLEX label of IBT-10PLEX reagent quantitative
Figure;
Fig. 3 (C): the accuracy-IBT-10PLEX label of IBT-10PLEX reagent quantitative is opposite to the sample of different proportion
Quantitative accuracy data figure;
Fig. 3 (D): the accuracy of IBT-10PLEX reagent quantitative-complex sample background marks IBT-10PLEX quantitative
Influence degree datagram
Fig. 4 (A): IBT-10PLEX reagent is for phosphoeptide in analysis-analysis HeLa cell of phosphoeptide in HeLa cell
Flow chart;
Fig. 4 (B): IBT-10PLEX reagent is for analysis-identification and quantification phosphoeptide of phosphoeptide in HeLa cell
Incremental data figure;
Fig. 4 (C): analysis-of the IBT-10PLEX reagent for phosphoeptide in HeLa cell becomes in different range relative abundance
The quantity of the phosphoeptide of change;
Fig. 4 (D): analysis-representativeness phosphoeptide of the IBT-10PLEX reagent for phosphoeptide in HeLa cell is relatively rich
Spend the curve changed over time.
Specific embodiment
With reference to the accompanying drawings and detailed description, the present invention is furture elucidated, it should be understood that following specific embodiments are only
For illustrating the present invention rather than limiting the scope of the invention.
The invention discloses a kind of isobar tagging reagents IBT-10PLEX reagent, isotopic tag reagent includes 10
The identical tagging reagents of chemical structure, the different location in each tagging reagents contain 13C or 15N isotope, same to position
Plain tagging reagents include: T-114, T-115N, T-115C, T-116N, T-116C, T-117N, T-118N, T-117C, T-118C,
T-119.Isotopic tag reagent include MS/MS can shear key and containing isotopic tag can with the group of polypeptides reactive,
Polypeptide is marked and is quantified;The structure of the isotopic tag reagent includes following formula: reporter group-balance group-activation
Group, wherein reporter group and balance group, which pass through MS/MS, can shear key connection, and activated group reacts to be formed with the amino of polypeptide
Stable amido bond;Reporter group+balance group quality in each reagent is identical;Contain isotopic tag reagent
Concrete structure formula is as follows:
Wherein, T-114, T-115N, T-115C, T-116N, T-116C, T-117N, T-118N;
Specific step is as follows:
1) 1 β-Ala-OBzl.HCl of compound and compound 2Boc-Gly-OH are coupled to compound 3;
2) compound 3 sloughs Boc group in acid condition, forms compound 4;
3) compound 4 and propionic aldehyde form compound 5 under reducing agent NaCNBH3 effect;
4) compound 5 and hydrogen slough Bzl blocking group under the catalytic action of palladium carbon and form compound 6;
5) compound 6 forms the IBT reagent compound 7 of activation with NHS under the action of dehydrating agent EDC;
Process route is as follows:
T-117C, T-118C, T-119 use raw material β-Ala-Obzl, Boc-Gly-OH, the third containing different isotopes
Aldehyde, the specific steps are as follows:
1) 2-Nosyl-Gly-OH (compound 8) reacts to form compound 9 with iodopropane;
2) compound 9 is deprotected under the conditions of 2 mercapto ethanol and potassium hydroxide and forms compound 10;
3) compound 11 is formed plus Boc blocking group on the second level amino of compound 10;
4) β-Ala-OBzl.HCl (compound 1) and compound 11 are coupled to compound 12;
5) compound 12 sloughs Boc group in acid condition, forms compound 13;
6) compound 13 and propionic aldehyde form compound 5 under reducing agent (NaCNBH3) effect;
7) compound 5 and hydrogen slough Bzl blocking group under the catalytic action of palladium carbon and form compound 6;
8) compound 6 forms the IBT reagent compound 7 of activation with NHS under the action of dehydrating agent EDC;
Process route is as follows:
T-114, T-115N, T-115C, T-116N, T-116C, T-117N, T-118N, T-117C, T-118C, T-119's
Shown in specific synthetic route following examples 1 and embodiment 2, of course, T-115N, T-115C, T-116N, T-116C, T-
It is 117N, T-118N, consistent with the route of T-114, it is T-117C, T-118C, consistent with the route of T-119.
The synthesis of embodiment 1:T-114, synthetic route are as follows:
The synthesis of T-114, asterisk represents 13C or 15N on corresponding position in synthetic route.
Compound 1 (β-Ala-OBzl.HCl, 13C3,15N, 215mg, 1mmol) and compound 2 (Boc-Gly-OH, 1-
13C, 175mg, 1mmol) it is dissolved in 20mL methylene chloride, it is added EDC.HCl (229mg, 1.2mmol), reaction is protected in argon gas
Shield is lower to be carried out 20 hours, and reaction solution is washed three times with 25mM dilute hydrochloric acid 30mL, is removed, is obtained with Rotary Evaporators after organic phase is dry
283mg oily compound 3 (84% yield).EtOAc solution (1M) stirring 2 that 50mL HCl is added in compound 3 (283mg) is small
When, the white precipitate of appearance is collected by filtration to obtain 205mg compound as white solid 4 (90% yield).Compound 4 (205mg) is molten
Solution is added propionic aldehyde (162 μ L, 130mg) in 20mL methanol, and 2 hours of 45mg sodium cyanoborohydride reaction are then added.With rotation
Turn evaporimeter and remove methanol, crude product methylene chloride: ethyl acetate (9:1) purifies obtain oily compound 5 on a silica gel column
(183mg, 76% yield).Compound 5 is dissolved in 20mL methanol, after 20mg Pd/C is added, reacts one under hydrogen balloon effect
A hour.It removes solvent and obtains compound as white solid 6 (125mg, 95% yield).Compound 6 (125mg) is dissolved in 20mL bis-
It in chloromethanes, is added EDC (130mg, 0.68mmol), NHS (115mg, 1mmol), reacts 20 hours under protection of argon gas.Reaction
Liquid is washed 3 times with 20mM sodium bicarbonate solution 30mL, is washed one time with saturated brine 30mL, is spin-dried for after organic phase is dry, is obtained white
Solid chemical compound 7 (IBT-114,142mg, 80% yield).NMR(400MHz,CD3OD):3.84(m,1H),3.50(m,1H),
3.29(s,2H),2.79(m,1H)2.72(s,4H),2.45(m,1H),2.50(m,4H),1.52(m,4H),0.85(t,6H)。
ESI-MS (M+H)+(calculating) 333.20, (actual measurement) 333.17.
The synthesis of embodiment 2:T-119, synthetic route are as follows:
The synthesis of T-119, asterisk represents 13C or 15N on corresponding position in synthetic route.
Compound 8 (Nosyl-Gly-OH, 15N, 2-13C, 524mg, 2mmol) is dissolved in 10mL DMF, and solid is added
Sodium carbonate (636mg, 6mmol) and iodopropane (590 μ L, 1.02g, 6mmol) stir 1 hour, filter white solid, and rotation is steamed
Hair removes major part DMF, and methylene chloride 30mL is added, washs 3 with 20mM sodium bicarbonate aqueous solution and saturated brine 50mL respectively
Time, it removes methylene chloride and obtains 654mg white compound 9 (95% yield).Compound 9 (654mg) is dissolved in the KOH/ of 20mL
In MeOH saturated solution, 400 μ L 2 mercapto ethanols are added, reaction is stirred 12 hours under nitrogen protection.Rotary evaporation removes first
Alcohol.Solid residue is directly dissolved in 10mL water, is adjusted to pH~10 or so with dilute hydrochloric acid, then, addition sodium hydroxide (80mg,
2mmol), dissolution Boc2O (525mg, 2.4mmol) is slowly added dropwise to the aqueous solution of compound 10, reaction 2 in 10mL acetone
Hour.Rotary evaporation remove acetone, with dilute hydrochloric acid adjust pH~2, ethyl acetate 20mL extract 3 times, it is organic mix after be evaporated
Obtain white compound 11 (350mg, 1.62mmol, 85% yield).
Compound 1 (β-Ala-OBzl.HCl, 215mg, 1mmol) and (Nosyl-Gly (the Pr)-OH, 15N, 2- of compound 11
13C, 220mg, 1mmol) it is dissolved in 20mL methylene chloride, it is added EDC.HCl (229mg, 1.2mmol), reaction is protected in argon gas
Shield is lower to be carried out 20 hours, and reaction solution is washed three times with 25mM dilute hydrochloric acid 30mL, is removed, is obtained with Rotary Evaporators after organic phase is dry
298mg oily compound 12 (0.8mmol, 80% yield).The EtOAc solution of compound 12 (298mg) addition 50mL HCl
(1M) is stirred 2 hours, and the white precipitate of appearance is collected by filtration to obtain 230mg compound as white solid 13 (0.74mmol, 92% production
Rate).Compound 13 (230mg) is dissolved in 20mL methanol, is added propionic aldehyde (13C3,80 μ L, 65mg), and 45mg cyano is then added
Sodium borohydride reacts 2 hours.Methanol is removed with Rotary Evaporators, crude product methylene chloride: ethyl acetate (9:1) is in silicagel column
Upper purification obtains oily compound 5 (160mg, 0.52mmol, 70% yield).Compound 5 is dissolved in 20mL methanol, is added
After 20mg Pd/C, a hour is reacted under hydrogen balloon effect.Remove solvent obtain compound as white solid 6 (115mg,
0.50mmol, 96% yield).Compound 6 (115mg) is dissolved in 20mL methylene chloride, addition EDC (130mg,
0.68mmol), NHS (115mg, 1mmol) reacts 20 hours under protection of argon gas.Reaction solution 20mM sodium bicarbonate solution
30mL is washed 3 times, is washed one time with saturated brine 30mL, is spin-dried for after organic phase is dry, obtain compound as white solid 7 (IBT-119,
120mg, 0.36mmol, 72% yield).NMR(400MHz,CD3OD):3.66(m,2H),3.41(d,1H),3.17(d,1H),
2.72(s,4H),2.61(m,3H),2.50(m,2H),2.38(m,1H),1.64(m,1H),1.52(m,2H),1.40(m,1H),
0.97(m,1.5H),0.85(t,3H),0.73(m,1.5H).ESI-MS (M+H)+(calculating) 333.20, (actual measurement) 333.35.
The invention also discloses a kind of IBT-10PLEX reagents to be used for polypeptide quantitative analysis, and key step includes label, point
Sub- fragmentation, quantitative three steps.After most 10 polypeptide samples can be marked respectively by IBT-10PLEX reagent, mix,
Then it is separated on liquid chromatogram LC, and then generates fragments characteristic peak and reagent reporter group in MS/MS, according to characteristic peak
Qualitative, quantitative analysis is carried out to polypeptide with the intensity of reporter group.
Wherein, polypeptide is prepared by the following:
(1) from the albumen of cell extraction
(2) pass through trypsin digestion
(3) desalination obtains mixtures of polypeptides
Wherein polypeptide is obtained from cell culture or other samples.
The preparation of sample may come from the protein ingredient extracted in the cell or other biological sample of culture.
Specific quantitative analysis method 3, embodiment 4, embodiment 5, embodiment 6 as the following examples.
The optimization of embodiment 3:IBT-10PLEX label reaction condition
The optimization of Fig. 1: IBT-10PLEX label reaction condition.(A) ratio of IBT-10PLEX reagent and peptide imitates label
The influence of rate.(B) influence of the label reaction time to labeling effciency.
As shown in Figure 1, the significant notation of polypeptide is the prerequisite with isobar reagent accurate quantitative analysis albumen.In general,
It can carry out the mark rate of representative peptide relative to the total quantity of the peptide of identification with the label peptide quantity of identification.For system optimization IBT
The condition of label mainly includes following several respects: 1) for dissolving the buffer TEAB (triethyl ammonium bicarbonate) of mixtures of polypeptides
Concentration, 2) ratio between labelled reagent and polypeptide sample, 3) the label time.Optimal label reaction condition is obtained by contrast
Are as follows: 1) the TEAB solution concentration for dissolving polypeptide sample is 200mM TEAB solution;2) ratio of IBT-10PLEX reagent and peptide
Rate is 10;3) label reaction Best Times are 2 hours.Therefore, in actual operation by IBT-10PLEX reagent be dissolved in
Polypeptide mixing in the triethyl ammonium bicarbonate of 200mM, is marked reaction.Label reaction is reacted at room temperature, and 2 hours
Trifluoroacetic acid (TFA) end mark process is added afterwards, and injected sample carries out separation analysis to sample into LC-MS/MS system.
Optimal LC-MS/MS mass spectral analysis condition needed for embodiment 4:IBT-10PLEX labelled protein quantitative analysis
Optimal LC-MS/MS mass spectral analysis condition needed for Fig. 2: IBT-10PLEX labelled protein quantitative analysis.(A) divide
The influence that resolution distinguishes reporter group ion.(B) NCE (orthogonal collision energy) to IBT labeling polypeptide identify and IBT report from
The influence of sub- intensity.
As shown in Fig. 2, LC-MS/MS mass spectral analysis condition optimal needed for IBT-10PLEX labelled protein quantitative analysis.
Liquid chromatogram separates the polypeptide sample after IBT-10PLEX label, and mixed sample (can up to 10 kinds mixing samples) can be adopted
With nanometer reverse phase (RP) chromatographic column (5- μm) Hypersil C18,75 μ m 150mm, Thermo Fisher Scientific)
Or the chromatographic column of similar functions carries out peptide molecule separation.10 kinds of molecular label quality of IBT-10PLEX reporter group are distinguished
Within the scope of 114 to 119Da, each reagent label contains the combination of the different number and location of independent 13C and/or 15N, no
The Tiny Mass difference of same isotopic molecule label carries out quality difference by high resolution mass spec, and realization analyzes and identifies and determines
Amount.The signal strength of signal reports ion for quantitative analysis is not less than the 5% of sample peak-peak.
In the proteomics based on label is quantitative, mass spectrographic resolution ratio, which influences, separates adjacent report ion (example
Such as, 115C is to 115N) and detection more polypeptide fragment between balance.By making sample with the tryptic digest of alpha-casein
To test the analysis parameter of MS2, compare and obtain with other MS2 using identical conclusion is reported, i.e., resolution ratio be 350000 string
Connection mass spectrum such as uses Orbitrap Q Exactive (Thermo Fisher Scientific, Waltham, MA) or similar functions
It is best that high-resolution mass spectrometer, which carries out identification and quantification analytical effect to the mixtures of polypeptides of label,.Meanwhile the standard of MS2 is hit
The value for hitting energy NCE compares analysis between 24% and 36%, the results showed that NCE value can reflect when being 30%
Determine to realize optimum balance between the segment of polypeptide and quantitative IBT reporter group quantity.
The accuracy of embodiment 5:IBT-10PLEX reagent quantitative
The accuracy of Fig. 3: IBT-10PLEX reagent quantitative.(A) assessment of IBT-10PLEX labeling effciency.(B)IBT-
The quantitative linearity scope of 10PLEX label.(C) accuracy of the IBT-10PLEX label to the sample relative quantification of different proportion.
(D) complex sample background marks quantitative influence degree to IBT-10PLEX.
As shown in figure 3,1) for the assessment of labeling effciency: being marked respectively using 10 kinds of different labels in IBT-10PLEX
The Hela cell extraction albumen of equivalent crossed through trypsin digestion.By the albumen sample of the equivalent marked by different labels after label
Product mixing, by LC-MS/MS identification and quantification, the results showed that, using quality be 114 molecular label label sample as control,
The sample size ratio of other 9 kinds of molecular labels label is close to 1.0.The label and quantitative result of 10 kinds of reagents of IBT-10PLEX
Between almost without quantitative deviation.
2) IBT-10PLEX quantifies the assessment of series range: multiple experiments confirm that the quantization series of IBT is at least up to 50 times.
First assessment experiment, the tryptic digest peptide of cow's serum (BSA) are to be tried respectively with independent IBT-10PLEX
Agent label, and mixed according to certain ratio, mixed proportion is 114:115N:115:116N:116C:117N:
117C:118N:118C:119=1:3:9:25:50:1:3:9:25:50.It is as a reference point with T-116C, report the intensity of ion
Linear relationship is presented within the scope of 50 times, with theoretical calculation (slope=1.10, R2=0.97).
Second assessment experiment, the tryptic digest peptide of HeLa cell protein is respectively by each IBT-10PLEX reagent mark
Note, and be to mix in varing proportions: 114:115N:115C:116N:116C:117N:117C:118N:118C:119=3:5:
10:1.5:1:1:1.5:10:5:3.Using T-117N as opposite reference value, find that most of sample measurement intermediate values are close after analysis
Desired value.
Third assessment experiment: the relative quantification result using Escherichia coli peptide as A in background check complex sample
Influence.The tryptic peptide of BSA is mixed, 114:115N by IBT-10PLEX separate marking with fixed proportion:
115C:116N:116C:117N:117C:118N:118C:119=1:2:4:8:10:1:2:4: 8:10;In comparative experiments, mix
The Escherichia coli peptide for entering equivalent is marked together with BSA, and wherein the mixed ratio of BSA remains as 1:2:4:8:10:1:2:4:
8:10.Two groups of experiments, finally total peptide amount is not equal after the sample mixing of isolabeling, and analyzes for LC-MS/MS.Do not drawing
In the group for entering Escherichia coli peptide, it is 0.97 that the slope for quantifying linear dependence, which is 0.83, R2 value, and is being mixed with Escherichia coli peptide
In background group, the slope of linear fit is 0.45, R2 0.96.Sample background magazine can generate label MS signal as the result is shown
It influences.But nevertheless, quantization be still it is linear, respective labels MS signal system decaying, do not influence quantitative result.
Therefore it is feasible that IBT carries out Relative quantification in the system with complex background.
Analysis of the embodiment 6:IBT-10PLEX reagent for phosphoeptide in HeLa cell
Analysis of Fig. 4: the IBT-10PLEX reagent for phosphoeptide in HeLa cell.(A) phosphoeptide in HeLa cell is analyzed
Flow chart.(B) quantity of the phosphoeptide of identification and quantification.(C) in the quantity of the phosphoeptide of different range relative abundance variation.
(D) curve that the relative abundance of representative phosphoeptide changes over time.
As shown in figure 4, analysis of the BT-10PLEX reagent for phosphoeptide in HeLa cell:
1) cell culture: the product HeLa cell bought from ATCC is maintained at provided and contains 10% fetal calf serum
(FBS) in DMEM solution, 37 DEG C of temperature control, and keep 5%CO2.Cell is provided in serum free medium and contains 150ng/
The EGF solution of mL carries out stimulation culture in 1,5,10,15,20,30,40,50 and 60 minute respectively.Different EGF thorns are contacted later
Cell is harvested by centrifugation in sharp groups of cells, and is washed twice with PBS to remove remaining EGF.
2) HeLa cell protein extracts, and digestion and label label: takes 300 grams to extract from different groups of HeLa cells respectively
Protein, by trypsin digestion and desalination.It is marked and is reacted with 1:10 (w/w) mixing with IBT-10PLEX reagent,
Enrichment extraction is carried out to phosphoeptide therein later.
3) enrichment and separation of phosphoeptide: the phosphoeptide of IBT label has the microballoon of TiO2 coating to be enriched with using surface,
It is carried out by high pH reverse phase classification separating kit (20mg, Thermo Scientific, Rockford, lL).Using different
It (is respectively 5,7,8,9,10,11,13,15,17,20,25 and 50% acetonitrile containing front three amine concentration that acetonitrile concentration, which gradually elutes,
Solvent).It is then combined with into 6 components and is separated and identified using LC-MS/MS.
4) mass spectral analysis condition: level-one MS1 scanning range is 350 to 2000m/z, scanning resolution 70000, lowest signal
Intensity is 20000.Second level MS/MS scanning resolution is that 35000. lowest signal-to-noises are set as 1.5.
5) database search: protein identification and quantitatively using iQuant software using iPeak search (drawn by three search
Hold up integrated MyriMatch v2.2.10165, X!Tandem v2017.2.1.2 and MS-GF+v2017.01.13).Identification of Fusion Protein
Utilize SwissProt human data library (in April, 2017 publication) and decoy sequence.Design parameter setting are as follows: the mirror of albumen and peptide
Determine error rate (FDR) to be set as less than 1%;Select trypsase as enzyme-specific, each peptide at most contains a mistake cutting;
Fixed modification includes IBT-10PLEX (N-term), IBT-10PLEX (K), carbamo, lmethyl (C) and variable modification packet
It includes oxidation (M), deamination (N, Q), IBT-10PLEX (Y) and phosphorylation (S, T, Y);MS1 quality error value 20ppm, MS2 segment
Quality error 0.1Da;The confirmation that only those phosphate phsophoRS score value is more than 0.75 is phosphate, and it is fixed to calculate phosphoeptide
The pval of amount is converted into qval value according to Cauchy distribution.
6) the Phospoprotein expression that IBT-10PLEX reagent quantitative is stimulated through EGF: phosphorylating protein group is in EGF difference
Between length (respectively 1,5,10,15,20,30,40,50,60 minutes) stimulation in produce Phospoprotein expression variation, benefit
The function that can mark and quantify up to 10 kinds different samples simultaneously with IBT-10PLEX reagent always identifies that albumen number is 1971
A, total phosphoeptide that identifies is 5361, wherein have a determining phosphorylation site has 4882.
Embodiment 7
Present embodiment discloses a kind of new isobar tagging reagents, isobar tagging reagents contain 13C's and 15N
Equivalent dystopy isotopic tag, isobar tagging reagents include following structure A, structure B, structure C, structure D or structure E
One or more of them:
The technical means disclosed in the embodiments of the present invention is not limited only to technological means disclosed in above embodiment, further includes
Technical solution consisting of any combination of the above technical features.It should be pointed out that for those skilled in the art
For, various improvements and modifications may be made without departing from the principle of the present invention, these improvements and modifications are also considered as
Protection scope of the present invention.
Claims (10)
1. a kind of polypeptide quantitative analysis method, it is characterised in that: use isobar tagging reagents, be marked and determine to polypeptide
Amount;Isobar tagging reagents include 10 kinds of labels.
2. a kind of polypeptide quantitative analysis method as described in claim 1, it is characterised in that: isobar tagging reagents include 10
A identical label of chemical structure, the different location in each label contain 13C or 15N isotope, 10 labels are as follows:
T-114、T-115N、T-115C、T-116N、T-116C、T-117N、T-118N、T-117C、T-118C、T-119。
3. a kind of polypeptide quantitative analysis method as claimed in claim 2, it is characterised in that: isobar tagging reagents include
MS/MS can shear key and can be marked polypeptide and quantifying containing isotopic tag with the group of polypeptides reactive;It is described
The structure of each label of isobar tagging reagents includes following formula: reporter group-balance group-activated group, wherein reporting
Group and balance group, which pass through MS/MS, can shear key connection, and activated group reacts to form stable amido bond with the amino of polypeptide;
Reporter group+balance group quality in each label is identical;Concrete structure formula containing isobar tagging reagents
It is as follows:
T-114, T-115N, T-115C, T-116N, T-116C, T-117N, T-118N, T-117C, T-118C, T-119 structural formula
As follows, wherein asterisk indicates that this position is corresponding 13C or 15N:
。
4. a kind of polypeptide quantitative analysis method as claimed in claim 3, it is characterised in that: reporter group and balance group pass through
MS/MS can shear key connection, and for the quality of reporter group in the range of 114 to 119Da, reporter group contains 10 kinds of differences respectively
Isotope 13C and 15N mass combination, balance group contains the isotope of corresponding 13C and 15N, reporter group and balance
The quality summation of group is completely the same in each reagent.
5. a kind of polypeptide quantitative analysis method as described in claim 1-4, it is characterised in that: polypeptide quantitative analysis includes following
Step: label, quantifies mass spectrometric fragmentation, polypeptide is marked using isobar tagging reagents, the polypeptide after label exists
Fragments characteristic peak is generated in MS/MS, and polypeptide is quantified according to the intensity of characteristic peak;
The polypeptide is prepared by the following:
(1) from the albumen of cell extraction
(2) pass through trypsin digestion
(3) desalination obtains mixtures of polypeptides.
6. a kind of isobar tagging reagents, it is characterised in that: isobar tagging reagents contain 10 kinds of equivalent of 13C and 15N
Dystopy isotopic tag, 10 labels are as follows: T-114, T-115N, T-115C, T-116N, T-116C, T-117N, T-118N, T-
117C,T-118C,T-119;Each equivalent dystopy isotopic tag includes 13C and/or 15N isotope atom;Isobar mark
Signing agent structure includes following formula: reporter group-balance group-activated group;Reporter group and balance group pass through can shear key
Connection, shear key are preferentially broken in MS/MS, are generated reporter group ion, are respectively provided with different molecular formula and quality, are reported
Specific molecular formula and the accurate mass for accusing group ion are as follows:
T-114, T-115N, T-115C, T-116N, T-116C, T-117N, T-117C, T-118N, T-118C, T-119 structural formula
As follows, wherein asterisk indicates that this position is corresponding 13C or 15N:
。
7. a kind of isobar tagging reagents as claimed in claim 7, it is characterised in that: the wherein quality of the reporter group
In the range of 114 to 119Da, the reagent contains the same position of the different number and location independently selected from 13C and/or 15N
Plain atom combination, and identification and analysis is carried out by mass spectrum;Steps are as follows for identification and analysis:
1) liquid chromatogram separation is carried out using nanometer reverse-phase chromatographic column;
2) it is analyzed using peptide identification of the Orbitrap Q Exactive high-resolution mass spectrometer to label;
3) it is at least the 5% of peak-peak using the signal strength of the signal reports group ion of quantitative analysis.
8. a kind of method for being synthetically prepared any one isobar tagging reagents of claim 6-7, it is characterised in that: use and contain
There are the raw material β-Ala-OBzl of different isotopes, Boc-Gly-OH, propionic aldehyde synthesizes 7 kinds of isobar labels according to following methods
T-114,T-115N,T-115C,T-116N,T-116C,T-117N,T-118N;
Specific step is as follows:
1) 1 β-Ala-OBzl.HCl of compound and compound 2Boc-Gly-OH are coupled to compound 3;
2) compound 3 sloughs Boc group in acid condition, forms compound 4;
3) compound 4 and propionic aldehyde form compound 5 under reducing agent NaCNBH3 effect;
4) compound 5 and hydrogen slough Bzl blocking group under the catalytic action of palladium carbon and form compound 6;
5) compound 6 forms the IBT reagent compound 7 of activation with NHS under the action of dehydrating agent EDC;
Process route is as follows:
。
9. a kind of method for being synthetically prepared any one isobar tagging reagents of claim 6-7, it is characterised in that:
Using the raw material β-Ala-Obzl containing different isotopes, Boc-Gly-OH, propionic aldehyde, according to following methods synthesize 3 kinds it is same
Measure dystopy tagging reagents, including T-117C, T-118C, T-119;Specific step is as follows:
1) 2-Nosyl-Gly-OH (compound 8) reacts to form compound 9 with iodopropane;
2) compound 9 is deprotected under the conditions of 2 mercapto ethanol and potassium hydroxide and forms compound 10;
3) compound 11 is formed plus Boc blocking group on the second level amino of compound 10;
4) β-Ala-OBzl.HCl (compound 1) and compound 11 are coupled to compound 12;
5) compound 12 sloughs Boc group in acid condition, forms compound 13;
6) compound 13 and propionic aldehyde are in reducing agent (NaCNBH3) compound 5 is formed under effect;
7) compound 5 and hydrogen slough Bzl blocking group under the catalytic action of palladium carbon and form compound 6;
8) compound 6 forms the IBT reagent compound 7 of activation with NHS under the action of dehydrating agent EDC;
Process route is as follows:
。
10. a kind of isobar tagging reagents, it is characterised in that: isobar tagging reagents contain the equivalent dystopy of 13C and 15N
Isotopic tag, the isobar tagging reagents include following structure A, structure B, structure C, structure D or structure E wherein
It is one or more:
。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910582411.9A CN110297056A (en) | 2019-06-29 | 2019-06-29 | A kind of preparation and application of isobar tagging reagents |
CN201911337499.4A CN111024867A (en) | 2019-06-29 | 2019-12-23 | High-throughput proteomics quantitative reagent based on stable isotope |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910582411.9A CN110297056A (en) | 2019-06-29 | 2019-06-29 | A kind of preparation and application of isobar tagging reagents |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110297056A true CN110297056A (en) | 2019-10-01 |
Family
ID=68029542
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910582411.9A Pending CN110297056A (en) | 2019-06-29 | 2019-06-29 | A kind of preparation and application of isobar tagging reagents |
CN201911337499.4A Pending CN111024867A (en) | 2019-06-29 | 2019-12-23 | High-throughput proteomics quantitative reagent based on stable isotope |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911337499.4A Pending CN111024867A (en) | 2019-06-29 | 2019-12-23 | High-throughput proteomics quantitative reagent based on stable isotope |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN110297056A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114573659A (en) * | 2021-12-17 | 2022-06-03 | 南京谱利健生物技术有限公司 | Solid phase synthesis method of high-throughput proteome quantitative reagent |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050147985A1 (en) * | 2004-01-05 | 2005-07-07 | Applera Corporation | Mixtures of isobarically labeled analytes and fragments ions derived therefrom |
US20050148087A1 (en) * | 2004-01-05 | 2005-07-07 | Applera Corporation | Isobarically labeled analytes and fragment ions derived therefrom |
US20050147982A1 (en) * | 2004-01-05 | 2005-07-07 | Applera Corporation | Mixtures of isobarically labeled analytes and fragments ions derived therefrom |
US20070048752A1 (en) * | 2004-07-12 | 2007-03-01 | Applera Corporation | Mass tags for quantitative analyses |
CN101421609A (en) * | 2006-01-24 | 2009-04-29 | 阿普里拉股份有限公司 | The method relevant, potpourri, kit and composition with analyte determination |
EP1918714A1 (en) * | 2006-11-02 | 2008-05-07 | Koninklijke Philips Electronics N.V. | Compounds and methods for double labelling of polypeptides to allow multiplexing in mass spectrometric analysis |
EP2015076A1 (en) * | 2007-07-11 | 2009-01-14 | Koninklijke Philips Electronics N.V. | Protein labelling with tags comprising isotope-coded sub-tags and isobaric sub-tags |
CN102174025B (en) * | 2011-01-18 | 2012-09-26 | 中国科学院上海有机化学研究所 | Isotope labeling reagent as well as preparation method and application thereof |
GB201521903D0 (en) * | 2015-12-11 | 2016-01-27 | Electrophoretics Ltd | Isorbaric mass labels |
CN109187940A (en) * | 2018-07-27 | 2019-01-11 | 南京谱利健生物技术有限公司 | The preparation and application of a kind of isotopic tag reagent for Analysis of polysaccharides |
-
2019
- 2019-06-29 CN CN201910582411.9A patent/CN110297056A/en active Pending
- 2019-12-23 CN CN201911337499.4A patent/CN111024867A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114573659A (en) * | 2021-12-17 | 2022-06-03 | 南京谱利健生物技术有限公司 | Solid phase synthesis method of high-throughput proteome quantitative reagent |
Also Published As
Publication number | Publication date |
---|---|
CN111024867A (en) | 2020-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101313223B (en) | Mass labels for biomolecules containing a 2,6-dimethyl-piperidin-l-yl methylene or a pyrimidin-2-yl thiomethylene mass marker moiety and a succinimid-oxy-carbonyl reactive functional group | |
DE60223696T2 (en) | GROUND MARKER | |
US9206225B2 (en) | Materials and methods for isolating phosphopeptides | |
EP1926997B1 (en) | Mass labels | |
DE69905265T2 (en) | CHARACTERIZATION OF POLYPEPTIDES BY CLEAVAGE AND MASS SPECTROMETRY | |
CN109142598B (en) | Donkey-derived characteristic peptides and method for identifying donkey-hide gelatin or donkey-hide gelatin product | |
CA2775118C (en) | Mass labels | |
CN103197081B (en) | A kind of protein chip and preparation thereof and detection method | |
GB2614128A (en) | Solid-phase N-terminal peptide capture and release | |
CN106855543A (en) | A kind of protein isotopic dilution tandem mass spectrum detection method based on chemical labeling techniques | |
CN110824083B (en) | Application of donkey-bone glue characteristic polypeptide in detection of donkey-bone glue components in animal skin glue and products thereof | |
WO2005042559A2 (en) | Capture and release based isotope tagged peptides and methods for using the same | |
CN110297056A (en) | A kind of preparation and application of isobar tagging reagents | |
CN109187940A (en) | The preparation and application of a kind of isotopic tag reagent for Analysis of polysaccharides | |
WO2005012247A1 (en) | Compounds and methods for the rapid quantitative analysis of proteins and polypeptides | |
US20100167262A1 (en) | Method and reagent for the specific identification and quantification of one or more proteins in a sample using in particular inductively coupled plasma-mass spectrometry | |
Shively et al. | Highlights of protein structural analysis | |
Stefanowicz et al. | Derivatization of peptides for improved detection by mass spectrometry | |
CN114371297A (en) | Method for enriching new-born protein by combining solid-phase enrichment with tandem enzyme digestion label | |
CN111205214B (en) | Stable isotope labeling reagent and preparation method and application thereof | |
CN101535316A (en) | Use of arylboronic acids in protein labelling | |
WO2019098291A1 (en) | Synthesis method of positron-emitting nuclide-labeled protein | |
JP2005049164A (en) | Labelling reagent and method for sensitively measuring and quantifying peptide | |
CN105866429B (en) | Biomolecular labeling and quantitative analysis method based on charged isotope reagent | |
CN116794198A (en) | New method for synthesizing and quantifying double rare earth metal marked peptide fragments applied to quantitative proteomics research |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20191001 |
|
WD01 | Invention patent application deemed withdrawn after publication |